165 related articles for article (PubMed ID: 31375715)
21. STAT3 ser727 phosphorylation and its association with negative estrogen receptor status in breast infiltrating ductal carcinoma.
Yeh YT; Ou-Yang F; Chen IF; Yang SF; Wang YY; Chuang HY; Su JH; Hou MF; Yuan SS
Int J Cancer; 2006 Jun; 118(12):2943-7. PubMed ID: 16425286
[TBL] [Abstract][Full Text] [Related]
22. p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial.
Sonnenblick A; Salgado R; Brohée S; Zahavi T; Peretz T; Van den Eynden G; Rouas G; Salmon A; Francis PA; Di Leo A; Crown JPA; Viale G; Daly L; Javdan B; Fujisawa S; De Azambuja E; Lieveke A; Piccart MJ; Bromberg JF; Sotiriou C
Int J Oncol; 2018 Feb; 52(2):424-432. PubMed ID: 29207087
[TBL] [Abstract][Full Text] [Related]
23. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
24. [Effect of Janus kinase inhibitor AG490 on invasion and metastasis of human breast cancer cells].
Chen HF; Deng HY; Fan WK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 39(1):63-5, 83. PubMed ID: 18390202
[TBL] [Abstract][Full Text] [Related]
25. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
27. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
[TBL] [Abstract][Full Text] [Related]
28. Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer.
Ko H; Lee JH; Kim HS; Kim T; Han YT; Suh YG; Chun J; Kim YS; Ahn KS
Biomolecules; 2019 May; 9(5):. PubMed ID: 31058868
[TBL] [Abstract][Full Text] [Related]
29. The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation.
McCormack D; Schneider J; McDonald D; McFadden D
Am J Surg; 2011 Nov; 202(5):541-4. PubMed ID: 21944294
[TBL] [Abstract][Full Text] [Related]
30. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
[TBL] [Abstract][Full Text] [Related]
31. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.
Lapeire L; Hendrix A; Lambein K; Van Bockstal M; Braems G; Van Den Broecke R; Limame R; Mestdagh P; Vandesompele J; Vanhove C; Maynard D; Lehuédé C; Muller C; Valet P; Gespach CP; Bracke M; Cocquyt V; Denys H; De Wever O
Cancer Res; 2014 Dec; 74(23):6806-19. PubMed ID: 25252914
[TBL] [Abstract][Full Text] [Related]
32. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.
Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY
Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787
[TBL] [Abstract][Full Text] [Related]
33. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
34. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
[TBL] [Abstract][Full Text] [Related]
35. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
[TBL] [Abstract][Full Text] [Related]
36. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
[TBL] [Abstract][Full Text] [Related]
37. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.
Berishaj M; Gao SP; Ahmed S; Leslie K; Al-Ahmadie H; Gerald WL; Bornmann W; Bromberg JF
Breast Cancer Res; 2007; 9(3):R32. PubMed ID: 17531096
[TBL] [Abstract][Full Text] [Related]
38. The association of D-dimer with clinicopathological features of breast cancer and its usefulness in differential diagnosis: A systematic review and meta-analysis.
Lu Y; Zhang L; Zhang Q; Zhang Y; Chen D; Lou J; Jiang J; Ren C
PLoS One; 2019; 14(9):e0221374. PubMed ID: 31487295
[TBL] [Abstract][Full Text] [Related]
39. pSTAT3 expression associated with survival and mammographic density of breast cancer patients.
Radenkovic S; Konjevic G; Gavrilovic D; Stojanovic-Rundic S; Plesinac-Karapandzic V; Stevanovic P; Jurisic V
Pathol Res Pract; 2019 Feb; 215(2):366-372. PubMed ID: 30598340
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and prognostic value of CD24 expression in breast cancer: a meta-analysis.
Liu G; Liu GX; Fang Y; Cao ZY; Du HH; Fu J; Qian K
Int J Biol Markers; 2017 May; 32(2):e182-e189. PubMed ID: 28315505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]